nDatalyze Corp (NDAT) AI Stock Analysis

• Market Cap: C$619.91K
• Dividend Yield: N/A
• Average Volume (3M): 0.00
• Price to Earnings (P/E): ―
• Beta (1Y): 1.09
• Revenue Growth: -100.00%
• EPS Growth: 65.85%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 41,327,423
• 10 Day Avg. Volume: 0
• 30 Day Avg. Volume: 0
• PEG Ratio: >-0.01
• Price to Book (P/B): 2.34
• Price to Sales (P/S): 732.04
• P/FCF Ratio: -2.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: C$0.01 ▼(-30.00% Downside)

The score is weighed down primarily by severe revenue contraction, persistent losses, and ongoing negative free cash flow, which together elevate operating and funding risk despite having no debt. Technicals are also weak with the price below major moving averages, while the recent positive platform milestone provides some support but is not yet validated by revenue traction or profitability.

Positive Factors

No Debt

Having no debt provides financial stability and flexibility, allowing the company to invest in growth opportunities without the burden of interest payments.

Product Innovation

Innovative AI-based tools enhance product offerings, potentially improving market position and customer satisfaction in mental health diagnostics.

Strategic Partnerships

The RTO with ThriveTech Holdings could broaden market reach and enhance capabilities, providing strategic growth opportunities and industry presence.

Negative Factors

Declining Revenue

Persistent revenue decline indicates challenges in market demand or competitive positioning, impacting long-term financial health and growth prospects.

Negative Cash Flows

Negative cash flows limit the company's ability to invest in growth and may necessitate external financing, affecting financial sustainability.

Operational Challenges

Ongoing operational inefficiencies hinder profitability and may require strategic adjustments to improve long-term business performance.

nDatalyze Corp Business Overview & Revenue Model

Company Description

nDatalyze Corp (NDAT) is a technology-driven company operating in the healthcare sector. It focuses on developing innovative mental health diagnostic tools and platforms leveraging artificial intelligence and machine learning technologies. The company's core product, the YMI (Your Mental Insight) platform, aims to provide predictive insights and personalized mental health assessments to enhance mental healthcare delivery.

How the Company Makes Money

nDatalyze Corp generates revenue primarily through subscription-based access to its YMI platform. Healthcare providers, clinics, and individual users subscribe to the platform for its mental health assessment tools, which utilize advanced data analytics to offer personalized insights and recommendations. The company may also explore partnerships with healthcare organizations and technology firms to expand its market reach and enhance its service offerings. Additionally, nDatalyze may engage in research collaborations or licensing agreements to further monetize its proprietary technologies and data assets.

nDatalyze Corp Financial Statement Overview

Summary

nDatalyze Corp is facing financial difficulties characterized by declining revenues and persistent losses. The company maintains a strong equity position with no debt, which provides some financial stability. However, the negative cash flows and the need for external financing point to underlying operational challenges that need addressing to improve the financial health of the company.

Income Statement

nDatalyze Corp's income statement reveals a challenging financial environment. The company has experienced a significant decline in revenue from 2020 to 2024, with the latest year showing a dramatic drop in total revenue to 96,342. This results in negative EBIT and net income, leading to a negative net profit margin. Gross profit margin remains positive but shrinking. The consistent negative EBITDA margin indicates ongoing operational challenges.

Balance Sheet

The balance sheet shows a strong equity position with no debt, resulting in a favorable debt-to-equity ratio of 0. Stockholders' equity is healthy relative to total assets, but there is a declining trend in total assets and equity over the years. The equity ratio remains strong, showing the company is not highly leveraged. This stability in equity is a positive factor amidst declining revenues.

Cash Flow

Cash flow analysis indicates significant challenges, with negative operating and free cash flows persistently over recent years. The free cash flow growth rate is negative, showing deteriorating cash generation capability. However, the company has managed to maintain liquidity through financing activities, boosting cash reserves temporarily.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.71K	96.34K	171.22K	424.93K	662.77K
Gross Profit	1.55K	67.39K	44.84K	229.98K	376.73K
EBITDA	-636.00K	-429.24K	-1.23M	-1.17M	-688.51K
Net Income	-554.48K	-155.60K	-1.23M	-1.17M	-698.53K
Balance Sheet
Total Assets	560.64K	877.91K	862.01K	1.71M	872.95K
Cash, Cash Equivalents and Short-Term Investments	522.96K	794.10K	742.74K	1.60M	781.39K
Total Debt	0.00	0.00	0.00	0.00	0.00
Total Liabilities	24.48K	38.26K	289.27K	81.42K	71.87K
Stockholders Equity	536.16K	839.65K	572.74K	1.63M	801.08K
Cash Flow
Free Cash Flow	-466.14K	-221.64K	-1.03M	-1.14M	18.90K
Operating Cash Flow	-466.14K	-217.46K	-1.02M	-1.13M	20.75K
Investing Cash Flow	0.00	-4.17K	-4.39K	-13.85K	-1.84K
Financing Cash Flow	194.99K	273.00K	175.54K	1.95M	168.00K

nDatalyze Corp Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.02
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NDAT, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and above the 200-day MA of 0.02, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 42.22 is Neutral, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:NDAT.

nDatalyze Corp Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
NDAT	43 Neutral	C$619.91K	-2.68	-40.64%	―	-100.00%	65.85%
NEWU	42 Neutral	C$866.33K	-0.23	―	―	―	―
NARA	42 Neutral	C$8.01M	-1.73	―	―	―	81.01%
TMED	38 Underperform	C$755.08K	-0.23	―	―	―	-1188.37%

nDatalyze Corp Corporate Events

nDatalyze Corp. Advances Epitome Sports Analytics Platform with Key Milestone Completion

nDatalyze Corp. has completed a significant milestone for its Epitome sports analytics platform by finalizing data collection and calibration across multiple hockey teams. This achievement validates the platform’s analytical frameworks, reducing technical risks and paving the way for market analysis and commercialization. Epitome is designed to support personalized athlete development and organizational decision-making by providing insights into factors influencing long-term performance, rather than predicting specific outcomes. The company plans to focus on market segmentation and commercialization strategies targeting specialized hockey academies, junior teams, athlete parents, and scouts.

nDatalyze Corp. Receives Additional Deposit for RTO Progress

nDatalyze Corp., a company listed on the Canadian Securities Exchange, has announced an update regarding its Reverse Takeover (RTO) progress. The company has received an additional $20,000 good faith deposit from the RTO target, indicating continued commitment despite delays related to audit and tax opinion. Trading of the corporation’s shares will remain halted until the RTO is either completed or abandoned.

nDatalyze Advances in Predictive Sports Analytics and RTO Progress

nDatalyze Corp. has completed data collection for two WHL teams and is set to begin with an OUA team for its ‘Epitome’ predictive sports performance analytics project. The company is also progressing with its RTO, finalizing paperwork and share structure, although trading remains halted until completion.